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Abstract
Bacterial plasmids propagate through microbial populations via the directed process of
conjugative plasmid transfer (CPT). Because conjugative plasmids often encode antibiotic
resistance genes and virulence factors, several approaches to inhibit CPT have been described.
Bisphosphonates and structurally related compounds (BSRCs) were previously reported to disrupt
conjugative transfer of the F (fertility) plasmid in E. coli. We have further investigated the effect
of these compounds on the transfer of two additional conjugative plasmids, pCU1 and R100,
between E. coli. The impact of BSRCs on E. coli survival and plasmid transfer was found to be
dependent on the plasmid type, the length of time the E. coli were exposed to the compounds, and
the ratio of plasmid donor to plasmid recipient cells. Therefore, these data indicate that BSRCs
produce a range of effects on the conjugative transfer of bacterial plasmids in E. coli. Since their
impact appears to be plasmid type-dependent, BSRCs are unlikely to be applicable as broad
inhibitors of antibiotic resistance propagation.
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The horizontal transfer of genetic material between bacterial cells increases the genetic
diversity of bacteria. For example, horizontal gene transfer (HGT) can lead to the rapid
dissemination of antibiotic resistance genes and bacterial virulence factors among bacterial
pathogens [1–3]. As a result, HGT is central to the emergence and spread of bacterial
species harboring antibiotic resistance genes [4,5]. Patient morbidity and mortality
drastically increases upon infection by antibiotic resistant bacteria because treatment options
for these patients are limited [4–6]. Motivated by these facts, several approaches to
inhibiting HGT have been pursued [7–13].
Conjugative plasmid transfer (CPT), a type of HGT, is a well-established route of antibiotic
resistance propagation in both laboratory and clinical settings [1–3]. During CPT, the
transferred (T) strand of a conjugative double stranded DNA (dsDNA) plasmid is unwound
from the parent strand and then transported from a donor to a recipient bacterium. For
successful DNA transfer, CPT relies upon two multi-protein complexes, the relaxosome and
the type IV secretion system (T4SS), linked by a type IV coupling protein (T4CP) [14–19].
Within the relaxosome complex, a highly conserved relaxase enzyme initiates and
terminates CPT using a series of metal-dependent DNA nicking steps [14,17,18].
Conjugative relaxases have been described as the anticipated targets of at least two classes
of CPT-specific inhibitors [9,10]. In the Lujan et al. work, produced by the same group as
the current study, the conjugative F plasmid relaxase was reported to be the target of
bisphosphonates, which were shown to disrupt the transfer of the F plasmid in E. coli. This
paper provided structural and in vitro DNA nicking activity data with the F plasmid
relaxase, as well as plasmid transfer data in the presence of bisphosphonates. Under the
published experimental conditions, inhibition of F plasmid transfer and selective killing of F
plasmid-harboring cells was reported for a specific set of bisphosphonates [10].
While the initial reported impact of bisphosphonates on F plasmid transfer was promising,
additional work was required to determine the range of plasmids and bacterial hosts that
might be sensitive to these compounds under different experimental conditions. Subsequent
structural data appeared to support the initial conclusion that relaxases were targeted by
BSRCs. Citrate, a putative BSRC-type inhibitor, was observed by our group bound to the
active site metal ion in the crystal structure of the plasmid pCU1 relaxase, an enzyme
homologous to the F plasmid relaxase [20]. Here we report an expanded study that seeks to
elucidate the impact of BSRCs on plasmid systems beyond the F plasmid. We found that the
effects of BSRCs are variable and are dependent on plasmid type and experimental
conditions.
Materials and Methods
In Cell Plasmid Transfer Experiments with the F, R100, and pCU1 Plasmids
Bacterial strains and plasmids are listed in Supplementary Table 1 along with the antibiotics
that were used to select for each strain and their subsequent transconjugants. Concentrations
of each antibiotic necessary to select for each strain were established by minimum inhibitory
concentration (MIC) tests performed by serial dilution to determine the antibiotic resistance
profiles of the strains used.
A protocol for following transfer of plasmids F, R100, and pCU1 from their respective
donor strain into their respective recipient strain was modified from that published for
analysis of F plasmid transfer (Supplementary Figure 1) [10]. Modifications were necessary
to obtain optimal plasmid transfer conditions for new conjugative systems as well as to
Nash et al. Page 2













examine the effect of BSRCs (Supplementary Figure 2, Sigma-Aldrich) on F plasmid
transfer under conditions not previously studied. This protocol incorporates the use of
Oxygen Biosensor (OBS) plates (BD Biosciences) to determine the size of each cell
population (donor, D, recipient, R, transconjugant, T) at the end of the plasmid transfer
assay. OBS plates contain an oxygen-sensitive fluorophore embedded in a gel that fluoresces
(excitation wavelength of 485 nm, emission wavelength of 620 nm) in an anaerobic
environment. Following the addition of a population of bacterial cells, oxygen consumption
will cause an increase in the fluorescent signal of the gel. The time of rise in fluorescence
signal is logarithmically related to the size of the cell population initially placed into the well
[21].
Plasmid transfer between bacterial cells was analyzed using the following protocol. Cultures
of donor (D) and recipient (R) were grown to saturation overnight under antibiotic selection
in Luria Broth (LB, Fisher Scientific) at 37°C. Donors and recipients were then diluted into
LB such that they reached an OD600 of 0.5 simultaneously when grown without selection at
37°C.
In the case of plasmid pCU1 transfer, donor and recipient subcultures were then mixed in a 2
to 5 donor to recipient volume:volume ratio and pelleted at 5000×g. Pelleted cells were
resuspended in LB to increase the cell density by a factor of 4, and 250 μL of the
resuspended mixture of cells was applied to each well of a 96-well filter-bottom plate (0.2
μm hydrophobic PVDF membrane, Corning). The plate was centrifuged for 2 min at
3000×g to adhere the cells onto the filters and remove the LB. LB or LB + BSRC (250 μL)
was then applied to the 96-well filter-bottom plate to generate LB controls and experimental
samples, respectively. Filter-bottom plates were then incubated at 37°C for a designated
time period (2, 24, or 48 h). Following incubation, filter-bottom plates were centrifuged for
2 min at 3000×g to remove LB and LB + BSRC from the cells. Cells were resuspended in
250 μL LB and then diluted 4-fold in LB to generate the final samples and analyzed as
described below.
In the case of F and R100 plasmid transfer, donor and recipient subcultures were then mixed
at a ratio of 1:9 D:R, 1:1 D:R, or 9:1 D:R in the presence of LB or LB + BSRC to generate
LB controls and experimental samples, respectively. Reactions were incubated at 37°C for
100 min. After 100 min, reactions were centrifuged for 5 min at 3000×g to pellet the cells;
supernatant containing BSRC was removed. Pelleted cells were resuspended in an equal
volume of LB and analyzed as described below.
For analysis, samples were transferred to OBS plates to determine the effect each BSRC had
on the size of donor and recipient populations, and the number of transconjugants produced
during the duration of the assay. In assays involving the R100 plasmid (all mating ratios)
and the F plasmid (9:1 mating ratio), wells were covered with the minimal amount of heavy
mineral oil necessary to limit the reabsorption of oxygen into the LB media after the time of
rise in fluorescence. The addition of mineral oil to the wells did not alter the cell populations
determined from the assays (data not shown). To determine the relationship between signal
generated on an OBS plate and the absolute size of the cell population, LB controls, as
defined above, were serially diluted and analyzed both by the OBS plate on a PHERAstar
fluorescent plate reader (BMG Labtech) and by enumeration of colony forming units
(CFUs) on selective media. These data were combined to correlate the time delay of the rise
in fluorescence signal to a specific population size.
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Transfer of the Conjugative F and R100 Plasmids
The impact of BSRCs on CPT and bacterial cell survival was investigated using a series of
plasmid transfer assays in E. coli (Supplementary Figure 1). First, the populations of F
plasmid donor cells (D), recipient cells (R), and transconjugant cells (T) were examined over
four experimental days using two BSRCs - citrate, which was not examined in the original
study, and etidronate, which was previously examined (Figure 1) (Lujan et al., 2007). We
found that each compound exhibited significant day-to-day variability in impacting D, R,
and T populations in these assays. For example, on days 1 and 3, T populations were
abolished at low citrate concentrations, while on days 2 and 4, this effect was only seen at a
higher citrate concentration (Figure 1). As such, the standard error associated with the
effective concentration required for 50% inhibition of cell survival (EC50) across six BSRCs
were found to show significant variability for F plasmid studies using the experimental
methods described previously [10] (Figure 2A). As outlined below for other plasmid
systems (i.e., R100 and pCU1), a similar degree of dayto-day variability was also observed.
Taken together, these results show that inconsistent results across experimental days
confounded the ability to determine clear effects of BSRCs on plasmid-containing bacterial
cells.
We next examined R100, a conjugative plasmid closely related to the F plasmid [22].
Experimental conditions were altered slightly relative to those published for the F plasmid
[10] to enhance R100 transfer. Adjusting the conditions of transfer also allowed us to
determine the effects changes in experimental design would have on BSRC efficacy. In
particular, the ratio of R100 donors (D) to R100 recipients (R) was set at both the original
1D:9R ratio used when following F plasmid transfer and a new 1D:1R ratio. An exposure
time of 100 minutes was maintained, identical to that used when characterizing F plasmid
transfer. As shown in Figures 2B and 3A–B, the ratio of donor to recipient bacterial cells
had a significant impact on BSRC efficacy. For example, at a 1D:9R R100 ratio, etidronate
spared the R population relative to the D and T populations; at a 1D:1R ratio, etidronate's
impact on the three populations was statistically identical (Figure 2B).
We then tested the effects of plasmid donor (D) to plasmid recipient (R) ratio on the F
plasmid system. In particular, the efficacy of BSRCs in the presence of a 1D:9R ratio was
compared to their efficacy in the presence of a 9D:1R ratio. The results of these experiments
mirrored those generated for the R100 studies (Figure 2A–B, Figures 3A–B). Slight
differences in EC50 values of etidronate observed at 9D:1R ratios (Fig. 2B) disappeared
when 1D:9R ratios were used(Fig. 2A). Taken together, these F and R100 plasmid studies
highlight the effect bacterial cell population ratios have on BSRC efficacy.
Transfer of the Conjugative Plasmid pCU1
To expand the analysis of BSRCs beyond that of the F-like plasmid family, the conjugative
plasmid pCU1, isolated from Salmonella typhimurium [23,24], was also examined. The rate
of plasmid pCU1 transfer was found to be significantly slower than that of the F plasmid;
pCU1 plasmid transfer is known to be drastically enhanced when transfer occurs on a solid
medium [25]. Therefore, the previously published experimental conditions used to study the
transfer of the F plasmid [10] were modified to optimize pCU1 plasmid transfer, and to
explore the impact of these modifications on BSRC efficacy. In particular, the ratio of donor
to recipient cells was shifted from 1D:9R to 2D:5R, and the mating experiment was
performed on a filter, as opposed to liquid (see Materials and Methods). The timeline of the
experiment was also extended in an attempt to compensate for the slow rate of pCU1
plasmid transfer, and the concentration of donor and recipient cells was increased 4-fold
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during the experiment to increase the local concentration of potential mating pairs. In
particular, donors and recipients were allowed to mate (undergo plasmid transfer) in the
presence of each compound of interest for 2, 24, and 48 hours.
As shown in Figures 2C–E and 3C, these experiments revealed a time-dependence of BSRC
efficacy on cells containing pCU1. The impact on cell survival and plasmid transfer were
most dramatic when the cells were exposed to putative inhibitors for 24 hours (Figures 2C–
E). After 2 or 48 hours, in contrast, either a weak effect or no effect was observed (Figures
2C–E). For example, clodronate showed little efficacy against all three cell populations at 2
and 48 hours of exposure, but exhibited efficacy versus donor and, to a lesser extent,
transconjugant populations at 24 hours of exposure (see Figures 2C–E). Furthermore, it was
also noted that compound efficacy differed between plasmid types even at roughly the same
exposure time. Clodronate demonstrated some efficacy for F plasmid donor cells at 100
minutes of exposure (Figure 2A); however, the same compound at 2 hours of exposure
demonstrated no effect on any cell populations containing plasmid pCU1 (Figure 2C). Taken
together, these results establish significant variability between exposure times and plasmid
types for any effect by BSRCs on plasmid transfer and cell survival.
Impact of Metal Chelation during Plasmid Transfer Experiments
Finally, bisphosphonates are known metal chelators, and their role in the treatment of
osteoporosis relies upon this activity [26–28]. Thus, we compared the effects of the metal
chelator EDTA with those of etidronate on bacterial cell survival and plasmid transfer for E
coli containing either the F or R100 plasmids (Figures 4A and 4B, respectively). We find
little difference between these two compounds for both F- or R100-containing cells,
indicating that metal chelation may be the mechanism by which BSRCs elicit effects on
bacterial cell survival and plasmid transfer. In summary, the broader plasmid transfer
experiments presented here demonstrate time-, bacterial cell line-, and plasmid-specific
variability in the impact of BSRCs on bacterial cells, and point to a general metal chelation
effect rather than a relaxase-specific inhibition.
Discussion
We present an extended analysis of the potential impact of bisphosphonates and structurally
related compounds (BSRCs) on conjugative plasmid transfer in bacteria and on the survival
of bacterial cells containing conjugative plasmids. This follows a previous report from our
group, in which we indicated that BSRCs selectively disrupted bacterial conjugation by
targeting the relaxase enzyme [10]. The current study expands the scope of the investigation
by including additional BSRCs, two additional bacterial plasmids, and a range of new
experimental conditions. Data outlined in Figure 4 suggest that BSRCs exert their variable
effects via metal ion chelation, as EDTA appeared to act in a manner similar to etidronate.
EDTA was not examined in the previous study, although another metal chelating BSRC,
pamidronate, showed little impact in that study on F-plasmid presence in E. coli [10].
Regardless, bacterial cell survival is closely linked to the intra- and extracellular
concentration of metal ions, which are required cofactors for a range of processes but can be
cytotoxic at high concentrations [29–31]. The integrity of the outer membrane (OM) of gram
negative bacteria is maintained by the presence of divalent cations, which serve to stabilize
and organize lipopolysaccharide (LPS) in the OM [32]. As a result, EDTA is commonly
used to permeabilize the OM of gram-negative bacteria by chelating divalent cations, and
the efficiency of gram-negative cell lysis by lysozyme is enhanced by the presence of EDTA
[33–35]. Millimolar concentrations of citrate can also permeabilize the OM of gram-
negative bacteria by metal chelation, though citrate's cytotoxic effect is prevented by an
excess of MgCl2 [33,35].
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The data presented here further show that BSRCs exhibit variable effects on bacterial cell
survival and conjugative plasmid transfer (see Figures 1–3). Factors involved in this
variability include plasmid type, ratio of plasmid donor to plasmid recipient cell types, and
the time over which cells are exposed to BSRCs. Based on these results, we conclude that
BSRCs will fail to exert a consistent effect on the transfer of conjugative plasmids, which
often contain antibiotic resistance genes, in a clinical setting. Indeed, while in some
conditions BSRCs can appear potent (e.g., Figure 2C–E), they lack potency if a key variable
is changed (e.g., exposure time of bacteria to BSRCs). While the results presented here are
disappointing from the perspective of limiting the spread of antibiotic resistance, they clarify
the effect of BSRCs on the conjugation of additional plasmids in E. coli.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Bisphosphonates and related compounds variably affect conjugative plasmid
transfer.
• Conjugation of plasmids R100, pCU1 and F are differentially impacted by
BSRCs.
• Changes to mating protocols alter the observed effect of BSRCs on plasmid
transfer.
• Metal chelation may be the mechanism by which BSRCs exert their effects.
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Survival of donor, recipient, and transconjugant cell populations during F plasmid transfer in
the presence of citrate or etidronate. The fraction or percentage of each cell line which
survived, relative to the unexposed control, is provided for eight concentrations of citrate
and etidronate. Donor is shown in blue, recipient in red, and transconjugant in green.
Etidronate data are from Lujan et al. (2007). Error bars present on the plot of the averaged
data represent the standard error.
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EC50 values for plasmid transfer assays. The effective molar concentration required to kill
50% (the EC50) of donor (D), recipient (R), or transconjugant (T) cell populations for a
selection of bisphosphonates and structurally related compounds(BSRCs) during F (A,B),
R100 (B), and pCU1 (C,D,E) plasmid transfer assays. For each plot, the plasmid, time of
exposure to the compound(s), and mating ratio of donor to recipient cells (D:R) are
provided. Error bars represent the standard error associated with each measurement.
Etidronate and clodronate data in (A) are from Lujan et al. (2007).
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Survival of donor, recipient, and transconjugant cell populations during plasmid transfer.
Cell survival during F, R100, and pCU1 plasmid transfer assays. The percentage of each cell
line which survived, relative to the unexposed control, is provided for eight concentrations
of etidronate (A) , PCP (B), and citrate or etidronate (C). Donor is shown in blue, recipient
in red, and transconjugant in green. Error bars represent the standard error of each
measurement. The impact of etidronate and PCP (A and B) on cell survival was dependent
on the ratio of donor and recipient cell populations exposed to each compound. The impact
of citrate and etidronate (C) on cell survival was dependent on the time the mating cells
were exposed to each compound.
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Survival of donor, recipient, and transconjugant cell populations during F and R100 plasmid
transfer in the presence of etidronate or EDTA. Cell survival during F (A) and R100 (B)
plasmid transfer assays. The percentage of each cell line which survived, relative to the
unexposed control, is provided for eight concentrations of EDTA. For comparison, survival
curves following exposure of plasmids F and R100 to etidronate are provided. Donor is
shown in blue, recipient in red, and transconjugant in green. Error bars represent the
standard error of each measurement.
Nash et al. Page 14
Biochem Biophys Res Commun. Author manuscript; available in PMC 2013 August 10.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
